Literature DB >> 1347954

Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.

G A Higgins1, B J Jones, N R Oakley.   

Abstract

The purpose of the present study was two-fold. Firstly, to present a more comprehensive analysis of the disinhibitory effects of 5-HT1A receptor agonists after discrete dorsal raphe (DRN) injections (Higgins et al. 1988). Secondly, the effects of the 5-HT1B receptor agonist CGS12066B and the 5-HT1B/1C agonist mCPP were examined following injection into this nucleus. The increases in social interaction (SI) induced by intra-raphe injections of 8-OH DPAT (0.02-1 micrograms), buspirone (0.04-0.2 microgram), ipsapirone (0.2 microgram) and gepirone (0.2-1 micrograms) under a high light unfamiliar paradigm (HLU) were typically due to increased bout frequency, duration and a higher incidence of sniff, follow, allogroom behaviour. These increases were qualitatively similar to those seen in control animals tested under low light/familiar (LLF) conditions, thus supporting the belief that the drug-induced increases in SI reflected decreases in anxiety. Furthermore, at doses effective under the HLU condition, 8-OH DPAT, buspirone and gepirone failed to modify SI under conditions of minimal suppression (LLF paradigm). At doses which significantly increased punished responding in a water-lick conflict test 8-OH DPAT, ipsapirone and gepirone tended to also increase unpunished rates of drinking. However, in drug untreated rats, prior habituation to the test apparatus also increased unpunished drinking, suggesting some neophobia-induced suppression. At a comparatively high dose, the 5-HT1B agonist CGS12066B (2.5 micrograms), but not the putative 5-HT1B/1C agonist mCPP (0.5-12.5 micrograms), increased SI under the HLU condition.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347954     DOI: 10.1007/bf02801982

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  39 in total

1.  Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.

Authors:  B Söderpalm; S Hjorth; J A Engel
Journal:  Pharmacol Biochem Behav       Date:  1989-01       Impact factor: 3.533

2.  Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.

Authors:  A S Eison; M S Eison; M Stanley; L A Riblet
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

3.  Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

Authors:  J A Engel; S Hjorth; K Svensson; A Carlsson; S Liljequist
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

4.  Serotonin-releasing effects of substituted piperazines in vitro.

Authors:  D J Pettibone; M Williams
Journal:  Biochem Pharmacol       Date:  1984-05-01       Impact factor: 5.858

5.  Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT.

Authors:  H Gozlan; S El Mestikawy; L Pichat; J Glowinski; M Hamon
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

6.  Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

7.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists.

Authors:  J S Sprouse; G K Aghajanian
Journal:  Synapse       Date:  1987       Impact factor: 2.562

8.  Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.

Authors:  S Pellow; A L Johnston; S E File
Journal:  J Pharm Pharmacol       Date:  1987-11       Impact factor: 3.765

9.  Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on core temperature in the rat.

Authors:  V Hillegaart
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.

Authors:  C P VanderMaelen; G K Matheson; R C Wilderman; L A Patterson
Journal:  Eur J Pharmacol       Date:  1986-09-23       Impact factor: 4.432

View more
  13 in total

1.  A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus.

Authors:  L E Gonzalez; S E File
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

Review 2.  5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function.

Authors:  Alvaro L Garcia-Garcia; Adrian Newman-Tancredi; E David Leonardo
Journal:  Psychopharmacology (Berl)       Date:  2013-12-12       Impact factor: 4.530

3.  Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment.

Authors:  Vincent Martin; Lionel Mathieu; Jorge Diaz; Haysam Salman; Jeanine Alterio; Caroline Chevarin; Laurence Lanfumey; Michel Hamon; Mark C Austin; Michèle Darmon; Craig A Stockmeier; Justine Masson
Journal:  J Psychiatry Neurosci       Date:  2020-09-01       Impact factor: 6.186

Review 4.  Regulation of dorsal raphe nucleus function by serotonin autoreceptors: a behavioral perspective.

Authors:  Ross A McDevitt; John F Neumaier
Journal:  J Chem Neuroanat       Date:  2011-05-08       Impact factor: 3.052

5.  Bombesin receptors as a novel anti-anxiety therapeutic target: BB1 receptor actions on anxiety through alterations of serotonin activity.

Authors:  Zul Merali; Tania Bédard; Nick Andrews; Ben Davis; Alexander T McKnight; M Isabel Gonzalez; Martyn Pritchard; Pam Kent; Hymie Anisman
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

6.  Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram.

Authors:  Inbar Zohar; Liat Dosoretz-Abittan; Shai Shoham; Marta Weinstock
Journal:  Psychopharmacology (Berl)       Date:  2014-11-26       Impact factor: 4.530

7.  Exposure to an open-field arena increases c-Fos expression in a subpopulation of neurons in the dorsal raphe nucleus, including neurons projecting to the basolateral amygdaloid complex.

Authors:  M W Hale; A Hay-Schmidt; J D Mikkelsen; B Poulsen; J A Bouwknecht; A K Evans; C E Stamper; A Shekhar; C A Lowry
Journal:  Neuroscience       Date:  2008-10-04       Impact factor: 3.590

8.  Medial prefrontal cortical activation modulates the impact of controllable and uncontrollable stressor exposure on a social exploration test of anxiety in the rat.

Authors:  John P Christianson; Brittany M Thompson; Linda R Watkins; Steven F Maier
Journal:  Stress       Date:  2009-09       Impact factor: 3.493

9.  The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist.

Authors:  H Yasumatsu; Y Morimoto; Y Yamamoto; S Takehara; T Fukuda; T Nakao; M Setoguchi
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

Review 10.  5-HT1A receptor agonists: recent developments and controversial issues.

Authors:  J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.